Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

5 High Beta ETFs That Are in High Momentum

Published 05/27/2020, 02:30 AM
Updated 07/09/2023, 06:31 AM

Coronavirus vaccine hopes and recovery in travel pattern during the Memorial Day weekend led to a rally in the U.S. market. The small-cap index Russell 2000 is leading the gains, and crude oil is also advancing amid reopening of economies. The S&P 500 traded above 3,000 for the first time since March 5.

Efforts in formulating a coronavirus vaccine are ramping up. The World Health Organization has recognised some 10 prime candidates for these potential vaccines as these have entered clinical trials. Plus, 114 candidate vaccines are in preclinical evaluation stage.

Per WHO, these prime candidates for potential vaccine include mRNA-1273 vaccine by Moderna (NASDAQ:MRNA) Inc. MRNA, potential vaccine ‘ChAdOx1 nCoV-19’ from Oxford University, RNA vaccine candidate from the collaboration between U.S.-based Pfizer (NYSE:PFE) and German pharmaceutical company BioNtech, and DNA-based vaccine from INOVIO Pharmaceuticals INO. Novavax (NASDAQ:NVAX) NVAX said lately that it began human testing of its coronavirus vaccine candidate, and expects preliminary results for the trial in July.

Consumer spending is very important for U.S. economic wellbeing as it contributes 70% of the U.S. GDP.A measure of consumer confidence jumped to 86.6 this month from 85.7 in April, according to the Conference Board. Economists polled by Dow Jones expected consumer confidence of 82.3 in May.

Along with some analysts, we too believe that the CARES relief checks and widespread price discounting boosted their buying attitudes and probably led to the optimism. According to a new survey from Piper Sandler (NYSE:PIPR), about 47% of the respondents said recently they will head to restaurants as soon as they reopen.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

We all know that the leisure industry is the most-hurt by the pandemic. Data from hospitality firm STR showed hotel occupancy up 32.4% for the most recently reported week ended May 16, from 21.0% the period ended Apr 11. However, the latest data is still down 54% year over year. While these developments are upbeat for the markets, mammoth Fed and government stimuli are the other tailwinds.

Why High-Beta & Momentum Investing Is Intriguing Now

High Beta ETFs

Beta is directly related to market movement. Notably, high-beta funds tend to rise or fall more than the stock market and are thus more volatile. When markets soar, high-beta funds experience larger gains than the broader market counterparts and thus, outpace their rivals. Momentum investing might also be an intriguing idea for those seeking higher returns in a short spell. It looks to reflect profits from buying stocks that are sizzling on the market.

Against this backdrop, investors may choose to bet on the below-mentioned ETFs that have a beta greater than one and that have gained more than the S&P (NYSE:SPY) 500 past month.

ETF Picks

Invesco (NYSE:IVZ) S&P SmallCap Consumer Discretionary ETF (PSCD) – Up 4.9% on May 26

Beta: 1.02x

One-Month Gain: Up 40.31%

Zacks Rank: #3 (Hold)

Invesco KBW High Dividend Yield Financial ETF (KBWD) – Up 4.6% on May 26

Beta: 1.13x

One-Month Gain: Up 32.2%

Zacks Rank: #3

SPDR S&P Internet ETF (XWEB) – Up 0.3% on May 26

Beta: 1.05x

One-Month Gain: Up 34.8%

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Zacks Rank: #2 (Buy)

First Trust Small Cap Value AlphaDEX Fund (FYT) – Up 6.0% on May 26

Beta: 1.10x

One-Month Gain: Up 30.6%

Zacks Rank: #3

SPDR Portfolio S&P 1500 Composite Stock Market ETF (SPTM) – Up 1.4% on May 26

Beta: 1.09x

One-Month Gain: Up 14.6%

Zacks Rank: #1 (Strong Buy)

Want key ETF info delivered straight to your inbox?

Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Moderna, Inc. (MRNA): Free Stock Analysis Report

Novavax, Inc. (NVAX): Free Stock Analysis Report

Inovio Pharmaceuticals, Inc. (NASDAQ:INO): Free Stock Analysis Report

First Trust Small Cap Value AlphaDEX ETF (FYT): ETF Research Reports

SPDR SP Internet ETF (XWEB): ETF Research Reports

Invesco SP SmallCap Consumer Discretionary ETF (PSCD): ETF Research Reports

Invesco KBW High Dividend Yield Financial ETF (KBWD): ETF Research Reports

SPDR Portfolio SP 1500 Composite Stock Market ETF (SPTM): ETF Research Reports

To read this article on Zacks.com click here.

Zacks Investment Research

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.